The role of endothelin in FK506-induced vascular reactivity changes in rat perfused kidney

European Journal of Pharmacology

Volumn 517, Issue 1-2, 2005, Pages 92-96

  Tekes, Ender ^a   Soydan, Guray ^a   Tuncer, Meral ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Bosentan; Endothelin; Isolated perfused kidney and mesentery; Tacrolimus (FK506); Vascular reactivity

Indexed keywords

BOSENTAN; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; HYDROGENATED CASTOR OIL; NITROPRUSSIDE SODIUM; NORADRENALIN; SOLVENT; TACROLIMUS;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; INHIBITION KINETICS; ISOLATED ORGAN; KIDNEY BLOOD VESSEL; KIDNEY PERFUSION; MALE; MESENTERY; MESENTERY BLOOD FLOW; MESENTERY BLOOD VESSEL; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; RECORDING; VASOCONSTRICTION; VASODILATATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELINS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; MESENTERIC ARTERIES; NITROPRUSSIDE; NOREPINEPHRINE; PERFUSION; RATS; RATS, WISTAR; RECEPTORS, ENDOTHELIN; RENAL ARTERY; SULFONAMIDES; TACROLIMUS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 21344464733     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.05.029     Document Type: Article

References (23)

1. C. Amorena, A. Castro, A. Muller, and M.F. Villamil Direct vascular effects in the rat of the vehicles used for the intravenous and oral administration of cyclosporin A Clin. Sci. (Lond) 79 1990 149 154
2. A. Benigni, M. Morigi, N. Perico, C. Zoja, C.S. Amuchastegui, A. Piccinelli, R. Donadelli, and G. Remuzzi The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance Transplantation 54 1992 775 780
3. J.C. Chen, and P. Ma Mechanism of FK506-induced renal hypoperfusion and its reversion in rats Acta Pharmacol. Sin. 22 2001 1034 1038
4. M. Clozel, and J.P. Clozel Effects of endothelin on regional blood flows in squirrel monkeys J. Pharmacol. Exp. Ther. 250 1989 1125 1131
5. J.R. Cockcroft, J.G. Clarke, and D.J. Webb The effect of intra-arterial endothelin on resting blood flow and sympathetically mediated vasoconstriction in the forearm of man Br. J. Clin. Pharmacol. 31 1991 521 524
6. J.J. De Lima, H. Xue, L. Coburn, T.F. Andoh, D.A. McCarron, W.M. Bennett, and J.B. Roullet Effects of FK506 in rat and human resistance arteries Kidney Int. 55 1999 1518 1527
7. A. Epstein, A. Beall, J. Wynn, L. Mulloy, and C.M. Brophy Cyclosporine, but not FK506, selectively induces renal and coronary artery smooth muscle contraction Surgery 123 1998 456 460
8. S.M. Gardiner, A.M. Compton, and T. Bennett Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats Br. J. Pharmacol. 99 1990 107 112
9. T. Goodall, C.N. Kind, and T.G. Hammond FK506-induced endothelin release by cultured rat mesangial cells J. Cardiovasc. Pharmacol. 26 1995 482 485
10. T.A. Marsen, F. Weber, G. Egink, G. Suckau, and C.A. Baldamus Differential transcriptional regulation of endothelin-1 by immunosuppressants FK506 and cyclosporin A Fundam. Clin. Pharmacol. 14 2000 401 408
11. W.L. Miller, M.M. Redfield, and J.C. Burnett Jr. Integrated cardiac, renal, and endocrine actions of endothelin J. Clin. Invest. 83 1989 317 320
12. H. Nakahama, M. Fukunaga, M. Kakihara, M. Horio, Y. Fujiwara, Y. Fukuhara, N. Ueda, Y. Orita, and T. Kamada Comparative effects of cyclosporine A and FK-506 on endothelin secretion by a cultured renal cell line, LLC-PK1 J. Cardiovasc. Pharmacol. 17 1991 172 173
13. F.V. Ortola, B.J. Ballermann, S. Anderson, R.E. Mendez, and B.M. Brenner Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration J. Clin. Invest. 80 1987 670 674
14. J. Pernow, J.F. Boutier, A. Franco-Cereceda, J.S. Lacroix, R. Matran, and J.M. Lundberg Potent selective vasoconstrictor effects of endothelin in the pig kidney in vivo Acta Physiol. Scand. 134 1988 573 574
15. E. Schwertfeger, J. Wehrens, V. Oberhauser, A. Katzenwadel, and L.C. Rump Contractile effects of tacrolimus in human and rat isolated renal arteries J. Auton. Pharmacol. 21 2001 205 210
16. M.S. Simonson, and M.J. Dunn Renal actions of endothelin peptides Curr. Opin. Nephrol. Hypertens. 2 1993 51 60
17. T. Slowinski, T. Subkowski, P. Diehr, D. Bachert, L. Fritsche, H.H. Neumayer, and B. Hocher Interaction of the endothelin system and calcineurin inhibitors after kidney transplantation Clin. Sci. 103 2002 396 398
18. S.C. Textor, J.C. Burnett Jr., J.C. Romero, V.J. Canzanello, S.J. Taler, R. Wiesner, M. Porayko, R. Krom, G. Gores, and E. Hay Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation Kidney Int. 47 1995 1426 1433
19. J. Uchida, K. Miura, S. Yamanaka, S. Kim, H. Iwao, T. Nakatani, and T. Kishimoto Renal endothelin in FK506-induced nephrotoxicity in spontaneously hypertensive rats Jpn. J. Pharmacol. 76 1998 39 49
20. R. Venkataramanan, A. Jain, E. Cadoff, V. Warty, K. Iwasaki, K. Nagase, A. Krajack, O. Imventarza, S. Todo, and J.J. Fung Pharmacokinetics of FK 506: preclinical and clinical studies Transplant. Proc. 22 1990 52 56
21. H.K. Wong-Dusting, M. La, and M.J. Rand Mechanisms of the effects of endothelin on responses to noradrenaline and sympathetic nerve stimulation Clin. Exp. Pharmacol. Physiol. 17 1990 269 273
22. Z.H. Yang, V. Richard, L. von Segesser, E. Bauer, P. Stulz, M. Turina, and T.F. Luscher Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? Circulation 82 1990 188 195
23. E. Yaris, M. Tuncer, and M. Ilhan Actions of cyclosporin A preparation and Cremophor-EL in rabbit mesenteric artery and thoracic aorta in vitro Clin. Sci. (Lond) 83 1992 179 182